HMOX1 and neoplasm: Another study has shown that targeting HO-1 by shRNA and chemical inhibitor, tin protoporphyrin IX (SnPP), can impair KSHV-encoded G protein-coupled receptor (vGPCR)-induced survival, proliferation, transformation and tumor growth [14].